This clinical trial is focused on studying Multiple Myeloma, a type of cancer that affects certain cells in the bone marrow. The study is investigating the use of Dexamethasone, a medication that can be taken as an oral solution, tablet, or through injection, as an initial treatment for patients with advanced stages of this disease. The purpose of the study is to determine how well patients respond to this treatment after several cycles.

Participants in the study will receive Dexamethasone in one of its available forms, and their progress will be monitored over a period of time. The study aims to see if the treatment can help achieve a significant response in patients, which means either a complete or partial reduction of the disease symptoms. The study is designed to compare the effectiveness of Dexamethasone with other treatment options available for Multiple Myeloma.

The trial will involve several cycles of treatment, and the response of the patients will be assessed using specific criteria set by experts in the field. This study is important for understanding how Dexamethasone can be used effectively in treating Multiple Myeloma and may provide valuable insights into improving treatment strategies for this condition.